Overview of AI-Driven New Drug Development Skills

Abstract

In traditional drug development, long development cycles, high costs, and low efficiency are often unavoidable. With the rise of artificial intelligence (AI), all aspects of traditional pharmaceutical industry have undergone unprecedented changes. Through model training, drug development cycles can be significantly shortened and efficiency improved. This article reviews the changes brought about by AI to the drug development industry in the past three years, outlining the improvements AI has made to the pharmaceutical process, and contributing to future research in the pharmaceutical field.